Pathway enrichment analysis identified 26 KEGG pathways, including “proteoglycans in cancer” (hsa05205), “pathways in cancer” (hsa05200), “serotonergic synapse” (hsa04726), “Ras signaling pathway” (hsa04014), “PI3K-Akt signaling pathway” (hsa04151), “dopaminergic synapse” (hsa04728) and “FoxO signaling pathway” (hsa04068). The gene discussed is AKT1; the disease is cancer.